Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) EBITDA (2021 - 2025)

Historic EBITDA for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to $952000.0.

  • MDxHealth's EBITDA rose 12460.58% to $952000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$397000.0, marking a year-over-year increase of 9775.26%. This contributed to the annual value of -$14.7 million for FY2024, which is 2430.09% up from last year.
  • As of Q3 2025, MDxHealth's EBITDA stood at $952000.0, which was up 12460.58% from $1.4 million recorded in Q2 2025.
  • MDxHealth's 5-year EBITDA high stood at $17.5 billion for Q2 2022, and its period low was -$17.5 billion during Q3 2022.
  • Its 5-year average for EBITDA is $773.2 million, with a median of -$1.4 million in 2024.
  • Examining YoY changes over the last 5 years, MDxHealth's EBITDA showed a top increase of 21563.68% in 2022 and a maximum decrease of 23337.37% in 2022.
  • MDxHealth's EBITDA (Quarter) stood at $7.4 million in 2021, then surged by 215.64% to $23.4 million in 2022, then tumbled by 118.68% to -$4.4 million in 2023, then skyrocketed by 68.47% to -$1.4 million in 2024, then soared by 169.09% to $952000.0 in 2025.
  • Its EBITDA stands at $952000.0 for Q3 2025, versus $1.4 million for Q2 2025 and -$1.3 million for Q1 2025.